Celltrion Healthcare United Kingdom Limited

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2025	3	Value not published	3
2024	3	Value not published	3
2023	2	Value not published	2
2022	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierCelltrion Healthcare United Kingdom Limited

Source records

Published awards

Page 2 of 2 · 24 records.

Cytokine Modulators (Omalizumab)
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
End date in notice
Date not published
Value shown in notice
£9,253,091Value from the linked contract
Official source
Open the official Find a Tender notice for Cytokine Modulators (Omalizumab)
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
- This figure comes from the linked contract record. Overall totals continue to use the separately published award value.
View record references
Source
Find a Tender
Award or lot reference
ocds-h6vhtk-0581ea / 085133-2025-2
Denosumab (Osteoporosis) and Ferric Carboxymaltose
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Celltrion Healthcare United Kingdom Limited

Published records by year

Buyer relationships by value counted

Published awards

Cytokine Modulators (Omalizumab)

Denosumab (Osteoporosis) and Ferric Carboxymaltose

Cancer Medicines (Group 2)

Aflibercept Biosimilar